Recce Pharmaceuticals Ltd (ASX:RCE)
0.460
-0.020 (-4.17%)
At close: Mar 6, 2026
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 133.02 million as of March 6, 2026. Its market cap has increased by 33.42% in one year.
Market Cap
133.02M
Enterprise Value
133.47M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 133.02M, an increase of 547.40%. That is a compound annual growth rate of 20.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 125.28M |
| Botanix Pharmaceuticals | 122.00M |
| Actinogen Medical | 143.02M |
| Paradigm Biopharmaceuticals | 109.81M |
| Starpharma Holdings | 155.37M |
| Arovella Therapeutics | 96.57M |
| Tetratherix | 194.43M |
| Cynata Therapeutics | 81.92M |